The Emergo Group recently posted an advisory that the FDA has revised the fee charged for issuing medical device export certificates in response to higher costs and demand for these documents.

The FDA reports that its certificate fees have not increased since 2003, even though volume of certificates requested has doubled.

The new fees go into effect on September 1.